Products for Research Use Only
RegisterLogin

Beludavimab

CAT: 0804-HY-P99467-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99467-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Beludavimab (BMS 4182137; VIR 7832) is a monoclonal antibody targeting the spike glycoprotein of SARS-CoV-2. Beludavimab binds to recombinant spike protein receptor-binding domain (S-RBD) with an EC50 value of 14.9 ng/mL and a Kd of 0.21 nM[1].
CAS Number
2423016-74-2
Product Name Alternative
BMS 4182137; VIR 7832
UNSPSC
12352203
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/beludavimab.html
Purity
97.34
Solubility
10 mM in DMSO
Smiles
[Beludavimab]
Molecular Weight
(146.56 kDa)
References & Citations
[1]Andrea L. Cathcart, et al. The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2. bioRxiv. April 01, 2022.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
MBS5818848Beludavimab
GTR18337849Beludavimab Antibody
E55B0857Beludavimab (Reference antibody)
VK565096-01Research Grade Beludavimab
ICH5385-25mgBeludavimab Biosimilar - Research Grade
GTR18697276-01Beludavimab Human Monoclonal Antibody
GTR18780415-01(Beludavimab) Biosimilar Reference Antibody
A135565Beludavimab Biosimilar (Monoclonal, IgG1, kappa)
PX-TA1797-01Beludavimab Biosimilar - Anti-Spike RBD mAb - Research Grade
RA0649-01Beludavimab (Biosimilar Reference Antibody) (SARS-CoV-2 Spike RBD)

Popular Products